ABS0706 SUSTAINABILITY OF CLINICAL RESPONSE THROUGH 2 YEARS AMONG UPADACITINIB-TREATED PATIENTS WITH AXIAL SPONDYLOARTHRITIS: DATA FROM THE SELECT-AXIS 1 AND SELECT-AXIS 2 TRIALS.